Aurora Cannabis (ACB) Competitors $4.71 +0.31 (+7.05%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACB vs. BGM, WVE, MLYS, ETNB, COLL, DYN, ELVN, RCUS, CMRX, and CDMOShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Qilian International Holding Group (BGM), Wave Life Sciences (WVE), Mineralys Therapeutics (MLYS), 89bio (ETNB), Collegium Pharmaceutical (COLL), Dyne Therapeutics (DYN), Enliven Therapeutics (ELVN), Arcus Biosciences (RCUS), Chimerix (CMRX), and Avid Bioservices (CDMO). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. Qilian International Holding Group Wave Life Sciences Mineralys Therapeutics 89bio Collegium Pharmaceutical Dyne Therapeutics Enliven Therapeutics Arcus Biosciences Chimerix Avid Bioservices Qilian International Holding Group (NASDAQ:BGM) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk. Do analysts rate BGM or ACB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Which has preferable valuation and earnings, BGM or ACB? Qilian International Holding Group has higher earnings, but lower revenue than Aurora Cannabis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQilian International Holding Group$25.10M42.73-$1.44MN/AN/AAurora Cannabis$320.81M0.83-$48.62M$0.0594.20 Do insiders & institutionals have more ownership in BGM or ACB? 47.6% of Aurora Cannabis shares are owned by institutional investors. 58.7% of Qilian International Holding Group shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is BGM or ACB more profitable? Aurora Cannabis has a net margin of 0.42% compared to Qilian International Holding Group's net margin of 0.00%. Aurora Cannabis' return on equity of 0.59% beat Qilian International Holding Group's return on equity.Company Net Margins Return on Equity Return on Assets Qilian International Holding GroupN/A N/A N/A Aurora Cannabis 0.42%0.59%0.42% Which has more risk and volatility, BGM or ACB? Qilian International Holding Group has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.63, meaning that its share price is 63% more volatile than the S&P 500. Does the MarketBeat Community believe in BGM or ACB? Aurora Cannabis received 384 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformQilian International Holding GroupN/AN/AAurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% Does the media refer more to BGM or ACB? In the previous week, Qilian International Holding Group and Qilian International Holding Group both had 1 articles in the media. Qilian International Holding Group's average media sentiment score of 0.00 equaled Aurora Cannabis'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qilian International Holding Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAurora Cannabis beats Qilian International Holding Group on 10 of the 13 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$264.77M$1.15B$5.42B$7.70BDividend YieldN/AN/A5.44%4.33%P/E Ratio94.229.8722.1818.31Price / Sales0.838.52397.31107.09Price / Cash26.3510.4038.2034.62Price / Book0.581.466.834.25Net Income-$48.62M-$54.34M$3.20B$247.51M7 Day Performance6.08%26.27%5.79%6.08%1 Month Performance3.06%17.73%-5.53%-3.77%1 Year Performance-34.58%-33.19%16.85%4.60% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.2717 of 5 stars$4.71+7.0%N/A-40.7%$264.77M$320.81M94.221,340BGMQilian International Holding GroupN/A$9.65-3.6%N/AN/A$938.19M$25.10M0.00298Positive NewsWVEWave Life Sciences4.329 of 5 stars$6.00+6.2%$22.18+269.7%+33.7%$920.92M$108.30M-5.41240Short Interest ↑Positive NewsMLYSMineralys Therapeutics2.6647 of 5 stars$13.92+3.9%$33.00+137.1%+18.4%$873.97MN/A-3.8228Positive NewsGap UpETNB89bio2.9288 of 5 stars$5.92+7.1%$27.56+365.5%-25.8%$864.23MN/A-2.0340Options VolumeNews CoverageCOLLCollegium Pharmaceutical4.0946 of 5 stars$26.73+1.6%$43.60+63.1%-27.7%$858.89M$631.45M11.52210DYNDyne Therapeutics3.5547 of 5 stars$7.47+6.1%$47.46+535.4%-57.6%$845.01MN/A-2.10100Upcoming EarningsNews CoverageELVNEnliven Therapeutics1.9745 of 5 stars$17.19+4.1%$40.33+134.6%+2.3%$842.38MN/A-9.0550News CoverageRCUSArcus Biosciences2.3056 of 5 stars$7.67-6.2%$30.25+294.4%-47.6%$806.41M$258M-2.43500Analyst ForecastCMRXChimerix2.7795 of 5 stars$8.54+0.2%$8.53-0.1%N/A$801.09M$212,000.00-9.0990Upcoming EarningsAnalyst ForecastCDMOAvid Bioservices0.7195 of 5 stars$12.50+0.1%$12.25-2.0%+87.1%$799.18M$139.91M-5.23320High Trading Volume Related Companies and Tools Related Companies Qilian International Holding Group Competitors Wave Life Sciences Competitors Mineralys Therapeutics Competitors 89bio Competitors Collegium Pharmaceutical Competitors Dyne Therapeutics Competitors Enliven Therapeutics Competitors Arcus Biosciences Competitors Chimerix Competitors Avid Bioservices Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACB) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACB Stock Free ACB Stock Alerts